One-day IP academy Stockholm

One-day IP academy Stockholm
date
November 20, 2025
TIme
09:30 - 17:00 CET
Address

Karolinska Institutet Innovations, Nanna Svartz Väg 6a, Solna

Potter Clarkson's unique one-day IP Academy is specifically designed to provide you with a fast but comprehensive overview of each critical step in the IP process:

  • Identifying the IP you have.
  • Ensuring it is fully and properly protected.
  • Making sure your IP is ready to be commercialised and supported by the right commercialisation strategies.
  • Knowing what you need to do to enforce your IP rights, should they be threatened in any part of the world.

To underline how vital it is to manage your IP in totality rather than in isolation, all four sessions will be run by members of our patent, trade mark, and licensing & litigation teams to emphasise the business-critical overlap and interplay between the very different elements of a 21st-century IP portfolio.

What do I need to do next?

The programme is designed for individuals who have a basic to intermediate understanding of IP.

All the costs (including your lunch) are covered by the hosts so this unique opportunity is completely free of charge. The only expense for you is your travel to the Campus Solna on the day.

You can find more information about the program and the Academy profile in the attached document in on the righthand side.

Welcome to join us and learn everything you need to know about IP!

Fake weight-loss medications and new enforcement possibilities

Fake weight-loss medications and new enforcement possibilities

CJEU rules on hosting defence for EU platforms

CJEU rules on hosting defence for EU platforms

Potter Clarkson ranked in Managing IP's IP STARS 2026

Potter Clarkson ranked in Managing IP's IP STARS 2026

Combination therapies: IP considerations for synergistic biologic products

Combination therapies: IP considerations for synergistic biologic products

Perfect storm - four drivers behind the mRNA litigation wave

Perfect storm - four drivers behind the mRNA litigation wave

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

See All News